235 related articles for article (PubMed ID: 15274320)
1. Metals and metal compounds in cancer treatment.
Desoize B
Anticancer Res; 2004; 24(3a):1529-44. PubMed ID: 15274320
[TBL] [Abstract][Full Text] [Related]
2. Non platinum metal complexes as anti-cancer drugs.
Ott I; Gust R
Arch Pharm (Weinheim); 2007 Mar; 340(3):117-26. PubMed ID: 17315259
[TBL] [Abstract][Full Text] [Related]
3. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Brabec V; Nováková O
Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
[TBL] [Abstract][Full Text] [Related]
4. Complexes of metals other than platinum as antitumour agents.
Köpf-Maier P
Eur J Clin Pharmacol; 1994; 47(1):1-16. PubMed ID: 7988618
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Metals and metal derivatives in medicine.
Colotti G; Ilari A; Boffi A; Morea V
Mini Rev Med Chem; 2013 Feb; 13(2):211-21. PubMed ID: 23438056
[TBL] [Abstract][Full Text] [Related]
7. Rhodium, iridium, copper and gold antitumor organometallic compounds (review).
Haiduc I; Silvestru C
In Vivo; 1989; 3(4):285-93. PubMed ID: 2519867
[TBL] [Abstract][Full Text] [Related]
8. [Cytostatic non-platinum metal complexes: new perspectives for the treatment of cancer?].
Köpf-Maier P
Naturwissenschaften; 1987 Aug; 74(8):374-82. PubMed ID: 3309682
[TBL] [Abstract][Full Text] [Related]
9. Antitumoral activity of non-platinum xanthate complexes.
Friebolin W; Schilling G; Zöller M; Amtmann E
J Med Chem; 2005 Dec; 48(25):7925-31. PubMed ID: 16335917
[TBL] [Abstract][Full Text] [Related]
10. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives.
Abeysinghe PM; Harding MM
Dalton Trans; 2007 Aug; (32):3474-82. PubMed ID: 17680034
[TBL] [Abstract][Full Text] [Related]
11. Anti leukemia activity (L1210) of 6-mercaptopurine and its metallo complexes in mice.
Skinner SM; Lewis RW
Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):183-6. PubMed ID: 841179
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer drugs interfere with intracellular calcium signaling.
Florea AM; Büsselberg D
Neurotoxicology; 2009 Sep; 30(5):803-10. PubMed ID: 19465052
[TBL] [Abstract][Full Text] [Related]
13. Organometallic compounds in oncology: implications of novel organotins as antitumor agents.
Alama A; Tasso B; Novelli F; Sparatore F
Drug Discov Today; 2009 May; 14(9-10):500-8. PubMed ID: 19429510
[TBL] [Abstract][Full Text] [Related]
14. Transdermal delivery of inorganic complexes as metal drugs or nutritional supplements.
Fairlie DP; Whitehouse MW
Drug Des Discov; 1991 Dec; 8(2):83-102. PubMed ID: 1793777
[TBL] [Abstract][Full Text] [Related]
15. Guidelines in the medical treatment of Helicobacter pylori infection.
Dzieniszewski J; Jarosz M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
[TBL] [Abstract][Full Text] [Related]
16. Metals and metal compounds in carcinogenesis.
Desoize B
In Vivo; 2003; 17(6):529-39. PubMed ID: 14758717
[TBL] [Abstract][Full Text] [Related]
17. [A glimpse into a new discipline: medicinal inorganic chemistry].
Kórös E; Varga M
Acta Pharm Hung; 2000; 70(3-6):196-202. PubMed ID: 11379026
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer and exposure to metals: the epidemiological evidence.
Wild P; Bourgkard E; Paris C
Methods Mol Biol; 2009; 472():139-67. PubMed ID: 19107432
[TBL] [Abstract][Full Text] [Related]
19. Gallium and other main group metal compounds as antitumor agents.
Jakupec MA; Keppler BK
Met Ions Biol Syst; 2004; 42():425-62. PubMed ID: 15206110
[TBL] [Abstract][Full Text] [Related]
20. Metal-based antitumour drugs in the post genomic era.
Dyson PJ; Sava G
Dalton Trans; 2006 Apr; (16):1929-33. PubMed ID: 16609762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
